Koninklijke Philips N.V.
General ticker "RYLPF" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $26.1B (TTM average)
Koninklijke Philips N.V. does not follow the US Stock Market performance with the rate: -10.0%.
Estimated limits based on current volatility of 1.3%: low 24.78$, high 25.46$
Factors to consider:
- Company pays dividends (irregularly): last record date 2026-05-13, amount 1.00$ (Y3.99%)
- Total employees count: 234000 as of 1998
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [24.43$, 36.65$]
- 2026-12-31 to 2027-12-31 estimated range: [27.30$, 40.47$]
Financial Metrics affecting the RYLPF estimates:
- Positive: with PPE of 20.3 at the end of fiscal year the price was neutral
- Positive: 7.78 < Operating profit margin, % of 9.24
- Negative: negative Industry operating cash flow (median)
- Negative: Industry inventory ratio change (median), % of 0.74 > 0.27
- Positive: Inventory ratio change, % of -0.50 <= 0
- Positive: -4.44 < Investing cash flow per share per price, % of -3.49
- Positive: 1.89 < Return on assets ratio (scaled to [-100,100]) of 3.23
- Positive: 0.30 < Operating cash flow per share per price, % of 5.48
Short-term RYLPF quotes
Long-term RYLPF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €18,169.00MM | €18,021.00MM | €17,827.32MM |
| Operating Expenses | €18,284.00MM | €17,492.00MM | €16,179.94MM |
| Operating Income | €-115.00MM | €529.00MM | €1,647.38MM |
| Non-Operating Income | €-412.00MM | €-406.00MM | €-465.83MM |
| Interest Expense | €306.00MM | €337.00MM | €345.87MM |
| R&D Expense | €1,890.00MM | €1,747.00MM | €1,699.36MM |
| Income(Loss) | €-527.00MM | €123.00MM | €1,181.56MM |
| Taxes | €-73.00MM | €963.00MM | €281.89MM |
| Net Income(Loss)* | €-466.00MM | €-702.00MM | €895.66MM |
| Stockholders Equity | €12,028.00MM | €12,006.00MM | €10,952.90MM |
| Inventory | €3,491.00MM | €3,198.00MM | €2,868.93MM |
| Assets | €29,406.00MM | €28,976.00MM | €26,933.91MM |
| Operating Cash Flow | €2,259.00MM | €1,556.00MM | €1,171.56MM |
| Capital expenditure | €644.00MM | €676.00MM | €268.90MM |
| Investing Cash Flow | €-636.00MM | €-573.00MM | €-746.72MM |
| Financing Cash Flow | €-848.00MM | €-496.00MM | €106.96MM |
| Earnings Per Share** | €-0.50 | €-0.75 | €0.94 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.